Compare IKT & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IKT | OPFI |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | 445 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.1M | 254.2M |
| IPO Year | 2020 | N/A |
| Metric | IKT | OPFI |
|---|---|---|
| Price | $2.00 | $9.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $5.00 | ★ $14.25 |
| AVG Volume (30 Days) | ★ 933.5K | 440.2K |
| Earning Date | 03-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | ★ 57.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $97.52 |
| Revenue Next Year | N/A | $10.95 |
| P/E Ratio | ★ N/A | $67.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $7.36 |
| 52 Week High | $2.27 | $14.63 |
| Indicator | IKT | OPFI |
|---|---|---|
| Relative Strength Index (RSI) | 62.27 | 74.77 |
| Support Level | $1.43 | $9.69 |
| Resistance Level | $2.10 | $10.26 |
| Average True Range (ATR) | 0.11 | 0.32 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 100.00 | 81.56 |
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.